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Simplified Evaluation and Documentation of Data from 
Glucose Controlled Insulin Infusion System (GCIIS) 
Computerunterstützte Datenauswertung und Dokumentation beim Einsatz 
glukosekontrollierter Insulininfusionssysteme 
Klinik für Innere Medizin, Medizinische Hochschule Lübeck, West Germany 
Key-words: Glucose controlled insulin infusion, artificial beta cell, data processing, metabolic 
control in diabetes mellitus 
A computer-assisted method for complete processing of data from a glucose-controlled insulin 
infusion system (GCIIS) is demonstrated. All data are transferred directly from the GCIIS to a 
microcomputer by means of an interface. A BASIC computer programme has been developed for 
rapid calculation of mean blood glucose (MBG), an index of blood glucose control (M-value) and a 
measure of diabetic instability (MAGE) in order to assess the state of glycemic control. All GCIIS-
data as well as calculated parameters are stored on floppy disks and can be recorded by a printer-
plotter immediately after the GCIIS control period. The device is particularly useful for 
optimizing conventional subcutaneous insulin therapy by means of a GCIIS. 
Schlüsselwörter: Glukosegesteuerte Insulin-Infusion, künstliche Beta-Zelle, Meßdatenverarbei-
tung, Stoffwechselüberwachung beim Diabetes mellitus 
Eine computerunterstützte Methode zur vollständigen Datenverarbeitung beim Einsatz glukose-
kontrollierter Insulininfusionssysteme (GCIIS) wird vorgestellt. Mit Hilfe eines Interface werden 
alle Daten direkt vom GCIIS auf einen Mikrocomputer übertragen. Ein BASIC-Computerpro-
gramm wurde für die schnelle Berechnung von Kenngrößen des Glukosestoffwechsels (mittlerer 
Blutzucker, M-value als Index für die Blutzuckerkontrolle und MAGE als Maß für Blutzucker-
schwankungen) entwickelt. Sämtliche GCIIS-Daten werden ebenso wie berechnete Parameter 
und Klartextkommentare auf Floppy-Disks gespeichert und können von einem Printer-Plotter 
ausgedruckt werden. Die Methode erlaubt eine vollständige Verarbeitung sämtlicher GCIIS-
Daten am Krankenbett ; sie hat sich z. B. zur Überprüfung und Verbesserung der Stoffwechsel-





P. C. Scriba 
Introduction 
Three parameters for assessment of metabolic control 
in diabetic patients commonly used are: 1) the diurnal 
mean blood glucose concentration (MBG), 2) the so-
called M-value [11], the logarithmic transformation of 
the deviation of glycemia from an arbitrarily selected 
standard, and 3) MAGE [13] the mean amplitude of 
glycemic excursions. When applied to a few blood 
glucose values at selected time points during the course 
of the day, conventional mathematical evaluation of 
these parameters may be feasible. However, this is al-
most impossible during the use of a glucose controlled 
insulin infusion system (GCIIS). Complete processing 
of GCIIS-data would require the time-consuming key-
bord entry of a vast number of values into a calculator. 
For this reason, an interface between the GCIIS and a 
microcomputer has been employed to transfer all data 
directly at one minute intervals. Further, a BASIC com-
puter programme has been developed for rapid calcu-
lation of MBG, M-value and MAGE. Our bed-side 
method permits the complete processing and recording 
of GCIIS-data. 
Materials and methods 
A schematic diagram of the technical equipment is 
shown in figure 1. The patient is connected to the GCIIS 
(Biostator Controller, Life Science Instruments, Miles 
Laboratories, Elkhart, USA), the details of which have 
been described elsewhere [3, 4, 8]. By means of an inter-
face all data for blood glucose concentration (BG), 
insulin infusion rate (IR) and dextrose infusion rate 
(DR) are transferred directly from the GCIIS to a 
microcomputer (PC 800, Magirus Datentechnik, Lein-
felden-Echterdingen, West Germany) for further 
processing. The microcomputer provides the following 
functions (figure 1): 
1) Monitoring: BG, IR and DR are plotted continuously. 
2) Manual input: comments concerning e.g. the actual 
therapy can be entered via keybord. 
3) Calculations: a BASIC computer programme has 
been developed for the calculation of 
- MBG (mg/dl) = — I BG n i 
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Figure 1. Schematic diagram of device used for processing 
of GCIIS-data. 
M-value: The M-value is a quantitative index of the 
deviation of several blood glucose (BG) 
determinations in a twenty-four-hour 
period from an arbitrarily selected stan-
dard (120 mg/dl). The mathematical for-
mula was designed to give proportionately 
greater emphasis to hypoglycemia than to 
hyperglycemia: 
M-value 
1 n / 







The calculation of MAGE is based on a 
logical algorithm (figure 2). It is defined 
as the arithmetic mean of those glycemic 
excursions which satisfy the following 
conditions: 
1. The excursion (from blood glucose 
nadirs to peaks or vice versa) must 
exceed one standard deviation of the 
mean blood glucose of the same 
twenty-four-hour period. 
2. The succeding excursion in opposite 
direction (peak to nadir or vice versa) 
must also exceed one standard devia-
tion. 
3. The excursion must have the same di-
rection as the first excursion which 
exceeds one standard deviation and 
thus establishes the direction of calcu-
lation. 
4) Printer and Floppy Discs: All values for BG, IR, DR 
as well as comments which appear in their time-
related positions, and calculated parameters are 
plotted and documented on 5 inch floppy discs. 
The BASIC-programme may be obtained by interested 
investigators from the authors upon writing. 
Results 
Figures 3 and 4 show as an example the data obtained 
from an insulin-dependent diabetic patient treated by a 
combination of. s.c. insulin injections and feedback 
control by the GCIIS. The first control period shows the 
assessment of additional insulin requirements for opti-
mizing metabolic control. The patient received inter-
mediate insulin, 28 U in the morning and 16 U in the 
evening. The total amount of insulin given in addition 
by the GCIIS for feedback control was 24.3 U regular 
insulin. Insulin requirements were highest after break-
fast, lunch and evening snack. There was a tendency 
towards hypoglycemia during midnight, which was 
counterregulated by 7.7 g dextrose administered. 
According to these data the patient was placed on a new 
insulin regimen: 22 U intermediate plus 6 U regular 
insulin in the morning and 18 U intermediate insulin in 
the evening. A second control period six weeks later 
clearly showed improved metabolic control. The addi-
tional amount of insulin given by the GCIIS was 
reduced to 4.7 U. There was only a slight tendency to-
wards hypoglycemia during the night. Table 1 shows 
the parameters for metabolic control calculated for the 
two GCIIS runs using all data obtained from the 
system. 
Table 1. Parameters reflecting metabolic control calculated 
by complete evaluation of the two GCIIS runs. 
Run 1 Run 2 
MBG±SD (mg/100 ml) 120±35 101±20 
M-value 14 7 
MAGE (mg/100 ml) 72 53 
Number of excursions 5 4 
Discussion 
Glucose controlled insulin infusion systems have been 
successfully used to determine insulin requirements for 
conventional subcutaneous insulin therapy [1, 6, 9, 10] 
and for continuous subcutaneous or intravenous 
insulin infusion with portable pumps [5,14]. In order to 
assess the state of glycemic control, three parameters 
are commonly used: MGB, the mean of all blood glucose 
values; the M-value, a parameter indicating the 
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Figure 2. Flow diagram for calculation of MAGE. 
Abbreviations: G (T) = blood glucose level at time T; E (I) = blood glucose level of the I-th relative 
extreme; F = number of measurements (T from 1 to F); FI = number of relative extrema (I from 
1 to FI); J = duration of stationary relative extrema; L = indicates, whether all excursions are 
counted in peak-to-nadir (L = - 1 ) or in nadir- to-peak direction (L = +1); D = standard 
deviation; O, U = greatest relative maximum (O) and smallest relative minimum (U) during 
an interval. These values are tested according to the criteria for counted excursions; K, = total 
of excursions counted for MAGE; K> = number of excursions counted for MAGE. 
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Figure 3. Blood glucose (BG), insulin infusion rates (IR) and dextrose infusion rates (DR) in a 
diabetic patient on conventional s.c. insulin therapy during a 24-hour feedback control by the 
GCIIS. Constants: VAR 100, BI 130, FI 325, RD 25, BD 65, FD 240. Assessment of additional 
insulin requirements for optimizing s.c. therapy. 
duration and the degree of pathological blood glucose 
values, and MAGE, the mean amplitude of glycemic 
excursions, a measure of diabetic instability. 
The results of this study offe the possibility to calculate 
on the basis of minute to minute blood glucose 
measurements these parameters more exactly than at 
selected time points, as suggested by others [7 ]. In part i-
cular, the computer programme and the technical 
equipment employed have the following advantages: 
MGB, M-value and MAGE can be calculated immedia-
tely after the end of a GCIIS control period. To our 
knowledge, rapid calculation of MAGE from GCIIS-
data by means of a specific BASIC-computer pro-
gramme using a micro-computer has not been reported 
up to now. In 1982, Brunetti et al. [2] for the first time 
presented a computerized system for evaluation and 
documentation of GCIIS-data. However, the concept of 
these authors required data transmission from a mini-
computer to a computer center for mathematical and 
statistical analysis. Therefore, evaluation of metabolic 
parameters such as MAGE could not be performed as a 
bedside method. - Further, all data from each patient 
during a control period are stored on a floppy disc and 
can be printed at any time. This is of particular interest 
for evaluating and comparing treatment regimes 
during extended periods. 
Figures 3 and 4 illustrate the usefulness of our method 
for the improvement of therapy in a diabetic on conven-
tional subcutaneous insulin regimen. Obviously, the 
procedure can be applied likewise in order to determine 
the insulin requirements and the state of metabolic 
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Figure 4. GCIIS-data obtained from the same patient during a second 24-hour control period 
six weeks later. New insulin regimen calculated according to the data from the first GCIIS-run. 
Improved metabolic control. 
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control in preprogrammed insulin infusion therapy. 
Finally, the method is not confined to routine clinical 
management of diabetes mellitus. It can also be recom-
mended in critical care medicine. Preliminary results 
[12] have proved its usefulness in evaluating the meta-
bolic therapy with glucose-insulin-potassium infu-
sions guided by a GCIIS in patients with acute myo-
cardial infarction. 
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